Skip to main content
Signal8

Meckler Jeffrey A

SEC insider (Form 3/4/5 filer). CIK 0001506916. Director at Travere Therapeutics, Inc. (TVTX) and 1 other issuer. 28 reported Form 4/5 transactions since Sep 2024; latest on Sep 10, 2026. Located in SAN DIEGO, CA.

Companies Meckler Jeffrey A has filed insider reports for

  • Travere Therapeutics, Inc. (TVTX): Director
  • Indaptus Therapeutics, Inc. (INDP): Director, Officer, Co-Chief Executive Officer
Meckler Jeffrey A profile photo

Meckler Jeffrey A

CIK: 0001506916

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (21.4%)

Position reduction

Option Exercises (M)4 (14.3%)

Derivative conversions

Awards (A)9 (32.1%)

Compensation grants

Other (G, F, J, C, D, …)9 (32.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Travere Therapeutics, Inc. logo
TVTX

Travere Therapeutics, Inc.

Director
Indaptus Therapeutics, Inc. logo
INDP

Indaptus Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (28 total)

  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    Sep 10, 2026
    Sale
    Direct
    1.7K shares at avg. $65.39$111K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    Sep 10, 2026
    Exercise
    Direct
    10K shares at avg. $26.52$265K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    Sep 10, 2026
    Exercise
    Direct
    10K shares at avg. $17.44$174K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    Sep 10, 2026
    Sale
    Direct
    3.1K shares at avg. $68.09$211K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    Sep 10, 2026
    Sale
    Direct
    14K shares at avg. $67.46$944K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    Sep 10, 2026
    Sale
    Direct
    1.2K shares at avg. $66.15$79K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    May 19, 2026
    Award
    Direct
    4K shares-
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    May 4, 2026
    Sale
    Direct
    8K shares at avg. $45.00$360K
  • Travere Therapeutics, Inc. logo
    TVTX

    Travere Therapeutics, Inc.

    May 4, 2026
    Exercise
    Direct
    8K shares at avg. $16.33$131K
  • Indaptus Therapeutics, Inc. logo
    INDP

    Indaptus Therapeutics, Inc.

    Feb 11, 2026
    Disposition

    Warrants (right to buy)

    Direct
    3K shares-

1-10 of 28